期刊文献+

TGF-β、FGF-2和Ezrin在金黄地鼠口腔癌模型中的表达

Expression of TGF-β,FGF-2 and Ezrin in golden hamster oral cancer model
下载PDF
导出
摘要 目的研究TGF-β、FGF-2和Ezrin在7,12-二甲基苯并[A]蒽(7,12-dimethyl-benzo[A]anthracene,DMBA)诱导的金黄地鼠颊黏膜癌模型中的表达,探讨其在口腔癌癌变中的作用。方法在金黄地鼠的单侧颊囊黏膜涂抹0.5%的DMBA,获得不同病变组黏膜标本,进行免疫组织化学检测和相关性分析。结果在上皮中至重度异常增生和早期癌变组中,TGF-β的高表达率分别为75%和100%,FGF-2的高表达率为83%和72%,而Ezrin高表达率分别为79%和77%,明显高于正常黏膜组和单纯及轻度异常增生组,差异均有统计学意义(均P<0.01)。相关性分析显示,三者表达呈正相关(P<0.01)。结论 TGF-β、Ezrin、FGF-2可能共同在口腔癌癌变过程中起重要作用。 Objective To investigate the expression of TGF-β,Ezrin and FGF-2 in 7,12- dimethyl-benzo [A]anthracene( DMBA) induced golden hamster oral cancer model and evaluate the role of TGF-β,Ezrin and FGF-2 in oral mucosal precancerosis process. Methods The unilateral cheek mucosa of the golden hamsters was treated with 0. 5% DMBA and a series of samples were obtained. The expression of TGF-β,Ezrin and FGF-2 was examined by immunohistochemistry. Meanwhile,the correlation between the expressions of these three factors was analyzed. Results In moderate to severe epithelial dysplasia and early cancer groups the high TGF-β-positive rate was 75% and 100% respectively,while high FGF-2-posotive rates was 83% and 72% and high expression rate of Ezrin was 79% and 77%. Compared with mild epithelial dysplasia group and normal mucosa group,there was a significant difference( P 〈0. 01). Furthermore,there was a significant correlation among the expressions of TGF-β,Ezrin and FGF-2. Conclusions TGF-β,Ezrin and FGF-2 may play an important role and have an interaction effect in the carcinogenesis of oral squamous cell carcinoma.
出处 《武警医学》 CAS 2016年第8期774-777,共4页 Medical Journal of the Chinese People's Armed Police Force
基金 国家自然基金课题(30973338)
关键词 金黄地鼠口腔癌模型 口腔鳞癌 转化生长因子 碱性成纤维细胞生长因子 埃兹蛋白 golden hamster oral cancer model oral squamous cell carcinoma transforming growth factor-beta(TGF-β) basic fibroblast growth factor(FGF-2) Ezrin
  • 相关文献

参考文献12

  • 1Chen Y K, Lin L M. DMBA-induced hamster buccal pouch carcinoma and VX2-induced rabbit cancer as a model for hu- man oral carcinogenesis [ J ]. Expert Rev Anticancer Ther, 2010, 10:1485-1496.
  • 2Xu Y, Pasche B. TGF-13 signaling alterations and sus- ceptibility to colorectal cancer [ J ]. Hum Mol Genet, 2007, 16(R1): R14-R20.
  • 3Leask A, Abraham D J. TGF-I~ signaling and the fibrot- ic response [J]. FASEB J, 2004, 18(7) : 816-827.
  • 4Roberts A B, Wakefield L M. The two faces of transfor- ming growth factor beta in carcinogenesis [ J ]. Proc Natl Acad Sci, 2003, 100(15): 8621-8623.
  • 5Polnaszek N, Kwahi-Addo B, Peterson L E, et al. Fi- broblast growth factor 2 pro- motes tumor progression in an autochthonous mouse model of prostate cancer [ J ]. Cancer Res, 2003, 63 (18) : 5754-5760.
  • 6Ninck S, Reisser C, Dyckhoff G, et al. Expression pro- files of angiogenic growth factors in squamous cell carci- nomas of the head and neck [J]. Cancer, 2003, 106: 34-44.
  • 7Khanna C, Wan X, BOSE S, et al. The membrane-cy- toskelet on linker ezrin is necessary for osteosarcoma me- tastasis [J]. Nat Med, 2004, 10(2) :182-186.
  • 8Li Q, Wu M, Wang H, et al. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells [ J ]. Cancer Lett, 2008, 261 ( 1 ) : 55- 63.
  • 9Xie J J, Xu L Y, Xie Y M, et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcino- ma cells [j]. Cancer, 2009, 124(11): 2549-2558.
  • 10Moilanen J, Lassus H, Leminen A, et al. Ezrin immu- noreactivity in relation to survival in serous ovarian car- cinoma patients [ J ]. Gynecol Oncol, 2003, 90 ( 2 ) : 273- 281.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部